Antibody drug for prevention or treatment of autoimmune diseases
US-2024352108-A1 · Oct 24, 2024 · US
Use of gelsolin to diagnose and treat inflammatory diseases
US9316639B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9316639-B2 |
| Application number | US-201213455878-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 25, 2012 |
| Priority date | Mar 15, 2006 |
| Publication date | Apr 19, 2016 |
| Grant date | Apr 19, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention relates to the use of gelsolin to treat inflammatory diseases (e.g., rheumatoid arthritis) and to the use of gelsolin to diagnose, monitor, and evaluate therapies of inflammatory diseases (e.g., rheumatoid arthritis).
First claim
Opening claim text (preview).
We claim: 1. A method for treating a subject having an inflammatory disease comprising: administering to a subject in need of such a treatment an effective amount of plasma gelsolin to treat the subject, wherein the inflammatory disease is rheumatoid arthritis or inflammatory bowel disease. 2. The method of claim 1 , wherein the subject is otherwise free of indications calling for treatment with gelsolin. 3. The method of claim 1 , where…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9316639B2 cover?
- The invention relates to the use of gelsolin to treat inflammatory diseases (e.g., rheumatoid arthritis) and to the use of gelsolin to diagnose, monitor, and evaluate therapies of inflammatory diseases (e.g., rheumatoid arthritis).
- Who is the assignee on this patent?
- Stossel Thomas P, Magnuson Osborn Teresia Anna Charlotta, Leuchovius Eric, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification G01N33/564. Mapped technology areas include Physics.
- When was this patent published?
- Publication date Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).